ഓൾമെസാർടാൻ മിഡോക്സോമിൽ ഉയർന്ന രക്തസമ്മർദ്ദത്തെ ചികിത്സിക്കാനുള്ള ഔഷധമാണ്. 1995ൽ ഡൈച്ചി സാക്യോ കോർപരേഷൻ ആണ് വികസിപ്പിച്ചത്.

Olmesartan medoxomil
Clinical data
Trade namesOlmecip.
AHFS/Drugs.commonograph
MedlinePlusa603006
Pregnancy
category
  • C (D if used in second or third trimester)
Routes of
administration
Oral
ATC code
Legal status
Legal status
  • In general: ℞ (Prescription only)
Pharmacokinetic data
Bioavailability26%
MetabolismHepatic (cannot be removed by hemodialysis)
Elimination half-life13 hours
ExcretionRenal 40%, biliary 60%
Identifiers
  • (5-methyl-2-oxo-2H-1,3-dioxol-4-yl)methyl 4-(2-hydroxypropan-2-yl)-2-propyl-1-({4-[2-(2H-1,2,3,4-tetrazol-5-yl)phenyl]phenyl}methyl)-1H-imidazole-5-carboxylate
CAS Number
PubChem CID
IUPHAR/BPS
DrugBank
ChemSpider
UNII
KEGG
ChEMBL
Chemical and physical data
FormulaC29H30N6O6
Molar mass558.585 g/mol
3D model (JSmol)
  • O=C1O/C(=C(\O1)C)COC(=O)c2c(nc(n2Cc5ccc(c4ccccc4c3nnnn3)cc5)CCC)C(O)(C)C
  • InChI=1S/C29H30N6O6/c1-5-8-23-30-25(29(3,4)38)24(27(36)39-16-22-17(2)40-28(37)41-22)35(23)15-18-11-13-19(14-12-18)20-9-6-7-10-21(20)26-31-33-34-32-26/h6-7,9-14,38H,5,8,15-16H2,1-4H3,(H,31,32,33,34) checkY
  • Key:UQGKUQLKSCSZGY-UHFFFAOYSA-N checkY
 ☒NcheckY (what is this?)  (verify)